Text size Amgen had aid it expected its acquisition of Horizon Therapeutics to be completed in the first half of 2023. Dreamstime Horizon Therapeutics stock plunged 18% early Tuesday on reports that the Federal Trade Commission is set to challenge Amgen ’s $27.8 billion deal to buy the biotech company. The FTC is expected to … Read more
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/horizon-therapeutics-coupa-rivian-stock-market-movers-51670601817 Updated Dec. 12, 2022 7:35 am ET / Original Dec. 12, 2022 4:33 am ET Order Reprints Print Article
Amgen Inc. AMGN -2.42% is in advanced talks to buy drug company Horizon Therapeutics HZNP 0.39% PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company was the last of three suitors … Read more
